PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1989 February; 82(2): 107–108.
PMCID: PMC1292006

Congenital erythropoietic porphyria and congenital adrenal hyperplasia with evidence for hepatic delta-5 alpha-reductase deficiency.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (400K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Nicholson DC, Cowger ML, Kalivas J, Thompson RP, Gray CH. Isotopic studies of the erythropoietic and hepatic components of congenital porphyria and 'erythropoietic' protoporphyria. Clin Sci. 1973 Feb;44(2):135–150. [PubMed]
  • Stevens E, Frydman RB, Frydman B. Separation of porphobilinogen deaminase and uroporphyrinogen 3 cosynthetase from human erythrocytes. Biochim Biophys Acta. 1968 Jun 24;158(3):496–498. [PubMed]
  • Romeo G, Levin EY. Uroporphyrinogen 3 cosynthetase in human congenital erythropoietic porphyria. Proc Natl Acad Sci U S A. 1969 Jul;63(3):856–863. [PubMed]
  • Deybach JC, de Verneuil H, Phung N, Nordmann Y, Puissant A, Boffety B. Congenital erythropoietic porphyria (Günther's disease): enzymatic studies on two cases of late onset. J Lab Clin Med. 1981 Apr;97(4):551–558. [PubMed]
  • Grandchamp B, Deybach JC, Grelier M, de Verneuil H, Nordmann Y. Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and one patient with homozygous coproporphyria. Biochim Biophys Acta. 1980 May 22;629(3):577–586. [PubMed]
  • Romeo G, Kaback MM, Levin EY. Uroporphyrinogen 3 cosynthetase activity in fibroblasts from patients with congenital erythropoietic porphyria. Biochem Genet. 1970 Dec;4(6):659–664. [PubMed]
  • Romeo G, Glenn BL, Levin EY. Uroporphyrinogen 3 cosynthetase in asymptomatic carriers of congenital erythpoietic porphyria. Biochem Genet. 1970 Dec;4(6):719–726. [PubMed]
  • Eriksen L, Eriksen N. Porphyrin distribution and porphyrin excretion in human congenital erythropoietic porphyria. Scand J Clin Lab Invest. 1974 Jun;33(4):323–332. [PubMed]
  • Taddeini L, Watson CJ. The clinical porphyrias. Semin Hematol. 1968 Oct;5(4):335–369. [PubMed]
  • WATSON CJ, PERMAN V, SPURRELL FA, HOYT HH, SCHWARTZ S. Some studies of the comparative biology of human and bovine erythropoietic porphyria. AMA Arch Intern Med. 1959 Mar;103(3):436–444. [PubMed]
  • ROSENTHAL IM, LIPTON EL, ASROW G. Effect of splenectomy on porphyria erythropoietica. Pediatrics. 1955 Jun;15(6):663–675. [PubMed]
  • GROSS S. HEMATOLOGIC STUDIES ON ERYTHROPOIETIC PORPHYRIA: A NEW CASE WITH SEVERE HEMOLYSIS, CHRONIC THROMBOCYTOPENIA, AND FOLIC ACID DEFICIENCY. Blood. 1964 Jun;23:762–775. [PubMed]
  • Watson CJ, Bossenmaier I, Cardinal R, Petryka ZJ. Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria. Proc Natl Acad Sci U S A. 1974 Feb;71(2):278–282. [PubMed]
  • Haining RG, Cowger ML, Labbe RF, Finch CA. Congenital erythropoietic porphyria. II. The effects of induced polycythemia. Blood. 1970 Sep;36(3):297–309. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press